Executive SCholedochoduodenal fistula in Mainland China: a review of epidemiology, etiology, diagnosis and managementummary
Executive Summary
Choledochoduodenal fistula (CDF) is a rare pathological communication between the common bile duct and the duodenum. While biliary-enteric fistulas were first described in 1654, they remain a significant diagnostic and therapeutic challenge due to their nonspecific clinical presentation. This document synthesizes data from a comprehensive review of 728 cases in Mainland China published between 1983 and 2014.
Key findings include:
Primary Cause: Cholelithiasis (gallstones) is the leading etiology, accounting for nearly 74% of cases.
Demographics: The condition is more prevalent in females (57.14%) with a mean age of approximately 57 years.
Regional Prevalence: Southwest China reported the highest number of cases, likely due to a higher regional incidence of biliary stones.
Diagnostic Gold Standard: Endoscopic retrograde cholangiopancreatography (ERCP) is the most effective diagnostic tool, confirming 65.25% of cases.
Management: Treatment strategies are determined by the size of the fistula orifice and the severity of symptoms, ranging from conservative medical management for orifices <0.5 cm to complex biliary reconstruction for orifices >1.0 cm.
Epidemiology and Regional Distribution
Analysis of 48 papers involving 728 patients reveals distinct demographic and geographic patterns in the occurrence of CDF within Mainland China.
Patient Demographics
The incidence of CDF among patients undergoing ERCP is estimated between 2.53% and 5.3%. The patient population is characterized by:
Gender Distribution: A female-to-male ratio of 1:0.75. Of the 728 cases, 416 were female.
Age: The mean age for females is 57.3 years, while the mean age for males is 48 years. The overall age range spans from 18 to 82 years.
Geographic Distribution
The prevalence of CDF varies significantly across different regions of Mainland China:
The high concentration of cases in Southwest China is attributed to the higher local prevalence of gallstones, choledocholithiasis, hepatoliths, and biliary stenosis.
Etiology and Pathogenesis
CDF is primarily a complication of chronic inflammatory processes. Unlike Western populations, where cholecystoduodenal fistulas are more common, choledochoduodenal fistulas are the most frequent type in Asia.
Primary and Secondary Causes
Mechanisms of Formation
Mechanical Pressure: Stones impacted in the narrow parts of the common bile duct (CBD)—such as the duodenal papilla or the site where the duct enters the duodenum—exert pressure on the duct wall, leading to repeated inflammation, necrosis, and eventual perforation.
Malignancy: Tumors in the pancreas or periampullary region can obstruct the CBD, increasing internal pressure until the duct wall cracks, or directly penetrate local tissues through necrosis.
Iatrogenic Factors: Injuries can occur during CBD exploration (e.g., via rigid choledochal bougie), sphincteroplasty, or endoscopic sphincterotomy (EST).
Peptic Ulcers: Duodenal ulcers, typically in the duodenal bulb, can penetrate both the intestinal and biliary walls.
Clinical Presentation and Diagnosis
The diagnosis of CDF is notoriously difficult because symptoms are often minimal or mimic other biliary conditions.
Symptomatology
The most common symptoms identified in the 728 cases include:
Epigastric Pain: 80.91% (589 cases)
Jaundice: 54.26% (395 cases)
Fever: 50.69% (369 cases)
Nausea/Vomiting: 10.30% (75 cases)
Cachexia: Associated primarily with advanced tumors (anorexia, weight loss, ascites).
Rare presentations: Melena, kaolin stools, abdominal distension, and diarrhea.
Diagnostic Modalities
ERCP is the definitive diagnostic method, while traditional imaging often fails to provide a clear diagnosis.
ERCP: Confirmed 475 cases (65.25%).
Surgical Discovery: 169 cases (23.21%).
X-Barium Meal: 4.40%.
Other tools: T-tube cholangiography, MRCP, and gastroscope/duodenoscope are used less frequently.
Ultrasound and CT: Rarely useful for direct diagnosis but may indicate "pneumobilia" (air within the biliary system).
Classification Systems
Two primary classification systems are used to categorize CDF based on anatomical location, which helps inform treatment.
Ikeda and Okada Classification
Type I: Located on the longitudinal fold of the papilla.
Type II: Located on the posterior wall of the duodenal bulb.
Gong et al. Classification
Type A: Orifice is located >2 cm away from the papilla.
Type B: Orifice is located <2 cm away from the papilla.
Type C (Perapapillary CDF/PCDF): Orifice is located on the papilla fold.
Management Strategies
Treatment is controversial and must be tailored to the etiology, fistula size, and the patient's general condition.
Size-Based Surgical Strategies
Research by Li et al. suggests the following management protocols:
Therapeutic Options
Biliary Reconstruction: Utilized in 46.84% of cases, including side-to-side choledochojejunostomy or intrahepatic cholangiojejunostomy.
Endoscopic Sphincterotomy (EST): Used in 13.74% of cases.
Fistula Repair Surgery: 11.95%.
Conservative Management: Includes drug therapy for peptic ulcers or iatrogenic perforations (antibiotics and T-tube drainage to reduce pressure).
Laparoscopic vs. Open Surgery: While open surgery was traditionally preferred, laparoscopic cholecystectomy (LC) is increasingly successful as surgical skills improve, showing no significant intraoperative complications or deaths in reported cases.
Conclusion
Choledochoduodenal fistula is a rare but critical differential diagnosis for patients with recurrent epigastric pain and cholangitis. While diagnosis remains difficult due to nonspecific symptoms, the utilization of ERCP has significantly improved detection rates. Management is highly specialized, requiring a graduated approach based on the size of the fistula orifice. While surgical reconstruction remains a mainstay for larger fistulas, conservative and laparoscopic approaches are viable for specific patient profiles. Future management plans require further investigation to establish standardized therapeutic protocols.
